A case study on OncXerna Therapeutics, which is developing an AI-driven precision medicine platform that will match oncology patients with the best treatment options.
Co-CEOs Santiago Pujadas and Ngoc Thai said the funding will be put toward hiring and expanding the development of therapies and treatments for diseases with fewer available medical options.